数据智能(Data Intelligence):灵活动态设问,实时获取答案
——为癌症转化研究和肿瘤药物临床开发提供强有力的数据解决方案
数据驱动算法(Data-driven Algorithm):对肿瘤临床假设的灵活探
——为肿瘤临床假设的提出、优化、扩展和验证提供最优的解决方案
领星生物为生物技术和制药公司的肿瘤药物研发及商业化提供一个强大而灵活的平台。通过动态数据智能技术,实现灵活方便设问及即时获取答案。
领星自有的人工智能算法可以实现对临床假设的对照组,联合方案,生物标记物,以及适应症拓展等多维度变量的系统整合分析,获得最优临床假设选项,用于临床验证。

前瞻性队列富集
使用我们丰富的临床网络助力药企伙伴迅速开展队列扩展研究

领先的分析能力

多学科的分析团队
20+年的分析经验

AI驱动的云端数字系统
灵活及可定制化的架构
保障安全和隐私
方便且易操作的界面
AGIOS PHARMACEUTICALS
“我们对GenomiCare提供的高质量真实世界的数据分析结果及其科学家和开发人员快速,深入的技术支持感到非常满意。 GenomiCare团队在完整的数据分析以及定制化计算技术设计方面为我们提供了极大的帮助。 专业的生物信息学团队提供了高质量的真实世界论证,合理的分析结果和出色的报告,这些信息有助于我们对癌症药物从诸多层面展开探索。”
“We are very pleased with the high quality of the real-world data provided by GenomiCare, and the fast, in-depth technical support from its scientists and developers. The team at GenomiCare helped us immensely with full data access and implementation of customized computational pipelines. The professional bioinformatics team delivered high-quality real-world evidence, sound analysis results and remarkable reports that helped our cancer drug discoveries.”
MSD
结果驱动:GenomiCare团队致力于克服障碍,为实现目标而努力
展现职业道德和正直:GenomiCare团队在与客户的所有互动中均遵循高标准的信赖度和道德行为准则; 遵守利益相关者要求的所有法律,政策和法规。”
“Focus the whole team on delivering value for customers by understanding customers’needs: GenomiCare team is good at listening and understanding our needs, taking quick actions to fulfil them.
Drive results: GenomiCare team dedicated to overcome obstacles, hold themselves for achieving results.
Demonstrate ethics and integrity: GenomiCare team adhere to high standards of trustworthy and ethical behavior in all the interactions with customers; comply with all laws, policies and regulations that stakeholder required. ”